Drug
AS03 clinical trials
Also written AS03.
- studies test it
- 11
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Development codes
- AS03
- 11
Studies by the year they started
10 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 9
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 11
National Institute of Allergy and Infectious Diseases (NIAID) (10) · Biomedical Advanced Research and Development Authority (1)
Often tested with
Tested in the same studies.
MF59 (4) · BNT162 Vaccine (1) · 2019-nCoV Vaccine mRNA-1273 (1)
Studies
Open first, then newest update. How each study uses AS03 is read from its arms, and is right about nine times in ten.
Testing it · 11
- COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)CompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT05289037Written as AS03
- H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology AnalysesCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT02921997Written as AS03
- H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: ImmunologyCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT03014310Written as AS03
- Sanofi 2017 H7N9 With/Without AS03 in Adults/ElderlyCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT03312231Written as AS03
- 2017 A/H7N9 IIV RevaccinationCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT03738241Written as AS03
- Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4CompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT03318315Written as AS03
- Panblok H7 Vaccine Adjuvanted With AS03 or MF59CompletedPhase 2Biomedical Advanced Research and Development AuthorityNCT03283319Written as AS03
- H5N8 Mix and Match With or Without AS03 or MF59 in Healthy AdultsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02624219Written as AS03
- CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly PopulationsWithdrawnPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00964951Written as AS03
- H7N9 Mix and Match With AS03 and MF59 in Healthy AdultsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT01942265Written as AS03
- Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly PopulationsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00963157Written as AS03